美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Synthorx, Inc.

67.99

0.0000

成交量：- -

成交額：- -

市值：21.75億

市盈率：-27.91

高：67.99

開：67.99

低：67.99

收：67.99

52周最高：71.90

52周最低：11.05

股本：3,198.82萬

流通股本：613.38萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.4361

每股收益(LYR):-18.1135

淨資產收益率：-85.54%

總資產收益率：-31.68%

市淨率：14.31

市盈率(LYR):-3.75

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Synthorx, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

https://synthorx.com/

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Synthorx, Inc.(NASDAQ:THOR)於2014年1月以Alinos, Inc.之名創立，同年3月，更名為Synthorx, Inc.，總部位於美國加州La Jolla，全職僱員25人 (10/31/2018) ，是一家生物製藥公司，專註於延長和改善癌症和自身免疫性疾病患者的生活的藥物開發。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/THOR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"THOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THOR\",,,,,undefined,":{"symbol":"THOR","market":"US","secType":"STK","nameCN":"Synthorx, Inc.","latestPrice":67.99,"timestamp":1579726800000,"preClose":67.99,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":6133818,"shares":31988206,"eps":-2.436144,"marketStatus":"停牌","change":0,"latestTime":"01-22 16:00:00 EST","open":67.99,"high":67.99,"low":67.99,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.436144,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1772096400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":67.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THOR\",,,,,undefined,":{"symbol":"THOR","floatShares":6133818,"roa":"-31.68%","roe":"-85.54%","lyrEps":-18.113477,"shares":31988206,"dividePrice":0,"high":67.99,"amplitude":0,"preClose":67.99,"low":67.99,"week52Low":11.05,"pbRate":"14.31","week52High":71.9,"institutionHeld":0.8897,"latestPrice":67.99,"eps":-2.436144,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.436144,"open":67.99,"prevYearClose":69.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-05","symbol":"THOR","fiscalQuarterEnding":"2019/09","expectedEps":-0.5,"name":null,"time":"盤後","type":"earning","dateTimestamp":1572930000000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2019-08-01","symbol":"THOR","fiscalQuarterEnding":"2019/06","expectedEps":-0.36,"name":null,"time":"","type":"earning","dateTimestamp":1564632000000,"reportTimeType":"","actualEps":-0.39},{"market":"US","date":"2019-04-30","symbol":"THOR","fiscalQuarterEnding":"2019/03","expectedEps":-0.32,"name":null,"time":"","type":"earning","dateTimestamp":1556596800000,"reportTimeType":"","actualEps":-0.35},{"market":"US","date":"2019-03-12","symbol":"THOR","fiscalQuarterEnding":"2018/12","expectedEps":-0.12,"name":null,"time":"","type":"earning","dateTimestamp":1552363200000,"reportTimeType":"","actualEps":-0.89},{"market":"US","date":"2015-08-04","symbol":"THOR","fiscalQuarterEnding":null,"expectedEps":0.14,"name":null,"time":"盤後","type":"earning","dateTimestamp":1438660800000,"reportTimeType":"post","actualEps":0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THOR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"https://synthorx.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Synthorx, Inc.(NASDAQ:THOR)於2014年1月以Alinos, Inc.之名創立，同年3月，更名為Synthorx, Inc.，總部位於美國加州La Jolla，全職僱員25人 (10/31/2018) ，是一家生物製藥公司，專註於延長和改善癌症和自身免疫性疾病患者的生活的藥物開發。","exchange":"NASDAQ","name":"Synthorx, Inc.","nameEN":"Synthorx, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"THOR\",market:\"US\",,,undefined,":null}}